2026 DayOne Accelerator

About

A hybrid accelerator program designed for early-stage healthtech and techbio startups, offering equity-free participation, mentorship, and access to industry experts, along with potential cash grants and tailored services to support their growth and development.

Benefits

• 💰Equity-free Participation
  Startups can join the program without giving up equity.
• 🌟Access to Industry Experts
  Participants receive tailored support from experienced professionals in the field.
• 🎓One-to-One Mentorship
  Dedicated mentorship to help refine the startup's value proposition.
• 💵Cash Grant Funding
  Potential for up to CHF 50K in cash grant funding to support development.
• 🛠️ Tailored Services
  Up to CHF 50K in customized services to assist startups in their growth.
• 🏢Office Space
• 12months of office space at Switzerland Innovation Park Basel Area for operational support.

Eligibility Criteria

• Startups must be healthtech or techbio focused
• Open to early-stage startups from any country
• Must have raised less than $10 million in dilutive funding
• Startups can be pre-incorporation or incorporated
• Must be developing solutions relevant to pharma R&D

Participation Commitments

• Must submit an online application by May 31, 2026
• Participation involves a hybrid program with online mentoring and two in-person events in Basel
• Selected startups must attend a kickoff bootcamp on September 7-8, 2026, and a closing showcase in December 2026
• Up to 40 shortlisted startups will be invited for interviews on June 25 or 26, 2026

Target Sector

Healthtech & TechBio

Target Location

Global